2019 Medtronic — FDA/CISA advisories for MiniMed wireless authentication weaknesses
Data compromised
Device configuration and dosing-integrity risk factors in FDA/CISA advisories
Technical writeup
FDA and ICS-CISA published guidance for cyber weaknesses in certain insulin pump models enabling adjacent-radio attacks; coordinated disclosure focused on device integrity rather than a central database breach.
Root cause
Wireless authentication weakness in device telemetry stack (coordinated disclosure)